Medications

FDA approves Zoryve for atopic dermatitis

The U.S. Food and Drug Administration has approved Arcutis Biotherapeutics' Zoryve (roflumilast) cream, 0.15%, for the treatment of mild-to-moderate atopic dermatitis in adult and pediatric patients (ages 6 years and older).

Neuroscience

Study shows hairy skin does not become less sensitive with age

Our sense of touch is generally thought to decline with age, just like the other senses. However, a study has shown that age-related decline in sensitivity only happens in hairless skin like the tip of the index finger, but ...

Diabetes

Bisphenol A linked to reduced peripheral insulin sensitivity

Bisphenol A (BPA) administration is associated with reduced peripheral insulin sensitivity among healthy adults, according to a study presented at the annual meeting of the American Diabetes Association, held from June 21 ...

page 1 from 40